INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRICS
Abstract
Key words: newborns, intravenous immunoglobulin, autoimmune diseases, initial immunodeficiency.
(Voprosy sovremennoi pediatrii — Current Pediatrics. – 2010;9(4):114-118)
About the Authors
A.Yu. ShcherbinaRussian Federation
T.G. Kosachyova
Russian Federation
A.G. Rumyantsev
Russian Federation
References
1. Imback P., Barandun S., díApuzzo V. et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981; 1: 1228–1131.
2. Bendtzen K., Hansen M.B., Ross C., Svenson M. High avidity autoantibodies to cytokines. Immunol Today. 1998; 19: 209–211.
3. Aukrust P., Froland S.S., Liabakk N.B. et al. Release of cytokines, soluble cytokine receptors, and interleukin 1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood. 1994; 84: 2136–2143.
4. Dalakas M.C. Intravenous immune globulin therapy for neurologic diseases. Ann. Intern. Med. 1997; 126: 721–730.
5. Clarkson S.B., Bussel J.B., Kimberly R.P. et al. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N. Engl. J. Med. 1986; 314: 1236–1239.
6. Hahn A.F. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Neurology. 1998; 51: 16–21.
7. Eijkhout H.W., van der Meer J.W.M., Kallenberg C.G.M. et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. Ann. Intern. Med. 2001; 135: 165–174.
8. Olopoenia L., Young M., White D. et al. Intravenous immunoglobulin in symptomatic and asymptomatic children with perinatal HIV infection. J. Natl. Med. Assoc. 1997; 89: 543–547.
9. Molica S., Musto P., Chiurazzi F. et al. Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study. Haematologica. 1996; 81: 121–126.
10. Sullivan K.M., Kopecky K.J., Jocom J. et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N. Engl. J. Med. 1990; 323: 705–712.
11. Stoll B.J., Gordon T., Korones S.B., et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J. Pediatr. 1996; 129: 72–80.
12. Ohlsson A., Lacy J.B. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev. 2004; (1): CD001239.
13. Ochs H.D., Pinciario P.J. Octagam® 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases. J. Clin. Immun. 2004; 24(3): 309–314.
14. Debes A. Tolerability and safety of the intravenous immunoglobulin octagam: a 10-year prospective observational study. Pharmacoepidemiol Drug. Saf. 2007; 16(9): 1038–1047.
Review
For citations:
Shcherbina A., Kosachyova T., Rumyantsev A. INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRICS. Current Pediatrics. 2010;9(4):114-118.
Email this article 
